Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Published clinical research has characterised the compound in controlled trials: a Phase 2 obesity trial reported dose-dependent body-weight change in the study population (Jastreboff et al., 2023), and a separate Phase 2 trial investigated the GIP/GLP-1/glucagon agonist in people with type 2 diabetes (Rosenstock et al., 2023)
GLP-1 agonists reduce appetite, slow gastric emptying, and improve glycemic control through glucose-dependent insulin secretion
Our teams have generated the worlds most detailed insights into why patients respond differently to these medicines, said Steve Gardner, chief executive officer of PrecisionLife
That's why we're excited to share the remarkable benefits of Glutathione, an antioxidant that can lower inflammation and have a profound impact on how you feel and function
